elliptinium has been researched along with Breast Neoplasms in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (75.00) | 18.7374 |
| 1990's | 4 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellon, P; Bernadou, J; Canal, P; Soula, G | 1 |
| De Ranieri, E; Hardouin, A; Herlin, P; Heron, JF; Juret, P; Le Talaer, JY; Peny, J; Ryckelynck, JP; Schneider, P | 1 |
| Abele, R; Brugarolas, A; Cavalli, F; Clarysse, A; de Jager, R; Hansen, HH; Renard, G; Rozencweig, M; Siegenthaler, P | 1 |
| Couette, JE; Delozier, T; Juret, P; Le Talaer, Y | 1 |
| Amiel, JL; Brulé, G; Huertas, D; Le Chevalier, T; Mondésir, JM; Rouëssé, J; Sancho-Garnier, H; Tursz, T | 1 |
| Couette, JE; Delozier, T; Juret, P; Le Talaer, JY | 1 |
| Couette, JE; Delozier, T; Heron, JF; Juret, P; Le Talaer, JY | 1 |
| Amiel, JL; Brule, G; Callet, B; Droz, JP; Huertas, D; Le Chevalier, T; Le Pecq, JB; Paoletti, C; Rouesse, J; Sancho-Garnier, H; Tursz, T; Voisin, PM | 1 |
| Azab, M; Le Chevalier, T; Mondésir, JM; Rouëssé, J; Spielmann, M; Turpin, F | 1 |
| Atassi, G; Bisagni, E; Burbridge, M; Guilbaud, N; Jan, M; Kraus-Berthier, L; Pierré, A; Rouillon, MH; Saint-Dizier, D; Visalli, M | 1 |
| Kayitalire, L; Le Chevalier, T; Spielmann, M; Thomas, F; Toussaint, C; Tursz, T | 1 |
| Buzdar, AU; Esparza, LT; Fraschini, G; Holmes, FA; Hortobagyi, GN; Lichtiger, B; Ro, JS | 1 |
| Byrne, PJ; Greenspan, A; McCabe, MS; Rahman, A; Treat, J | 1 |
| Maftouh, M; Picard, C; Roché, H | 1 |
| Alberici, GF; Bidart, JM; Bohuon, C; Caille, P; Einzig, AI; Goodman, A; Gralla, RJ; Mondesir, JM; Rouesse, J; Troalen, F | 1 |
| Amiel, JL; Caille, P; De Jager, R; Le Chevalier, T; May-Levin, F; Mondesir, JM; Rouësse, JG; Sancho-Garnier, H; Spielmann, M | 1 |
5 trial(s) available for elliptinium and Breast Neoplasms
| Article | Year |
|---|---|
Hydroxy-9-methyl-2-Ellipticinium (NSC 264-137) in 52 cases of osseous metastases from breast cancer.
Topics: Alkaloids; Bone Neoplasms; Breast Neoplasms; Calcification, Physiologic; Clinical Trials as Topic; Ellipticines; Female; Humans; Middle Aged | 1980 |
[2 N methyl 9 hydroxy-ellipticine in treatment of metastatic breast cancers (author's transl)].
Topics: Alkaloids; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Ellipticines; Female; Hemolysis; Humans | 1981 |
[Hydroxy-9-methyl-2-ellipticinium (NSC 264-137) for osseous metastases from breast cancer. A 4 year experience (author's transl)].
Topics: Adult; Alkaloids; Bone Neoplasms; Breast Neoplasms; Clinical Trials as Topic; Dose-Response Relationship, Drug; Ellipticines; Female; Follow-Up Studies; Humans; Male | 1981 |
Phase II study of elliptinium acetate salvage treatment of advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Ellipticines; Female; Humans; Intercalating Agents; Middle Aged; Prospective Studies; Salvage Therapy; Xerostomia | 1993 |
Phase II study of a combination of elliptinium and vinblastine in metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Ellipticines; Female; Humans; Infusions, Intravenous; Intercalating Agents; Middle Aged; Neoplasm Metastasis; Vinblastine | 1992 |
11 other study(ies) available for elliptinium and Breast Neoplasms
| Article | Year |
|---|---|
Use of electrochemical detection in the high-performance liquid chromatographic determination of hydroxylated ellipticine derivatives.
Topics: Alkaloids; Antineoplastic Agents; Breast Neoplasms; Chromatography, High Pressure Liquid; Electrochemistry; Ellipticines; Female; Humans; Hydrogen-Ion Concentration; Infusions, Parenteral; Kinetics; Oxidation-Reduction; Spectrometry, Fluorescence | 1984 |
[Renal toxicity of 9-hydroxy-2-methyl-ellipticinium].
Topics: Acute Kidney Injury; Aged; Alkaloids; Antineoplastic Agents; Breast Neoplasms; Ellipticines; Female; Humans; Kidney; Kidney Tubules; Middle Aged; Retrospective Studies; Urologic Diseases | 1984 |
Phase II study of 9-hydroxy-2N-methylellipticinium acetate.
Topics: Adult; Aged; Alkaloids; Antineoplastic Agents; Bone Marrow Diseases; Breast Neoplasms; Carcinoma, Squamous Cell; Colonic Neoplasms; Drug Evaluation; Ellipticines; Female; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms | 1984 |
Hydroxy-9-methyl-2-ellipticinium for osseous metastases from breast cancer: a 5-year experience.
Topics: Alkaloids; Bone Marrow; Bone Neoplasms; Breast Neoplasms; Digestive System; Drug Evaluation; Ellipticines; Female; Humans; Kidney; Xerostomia | 1982 |
[N-Methyl-9 hydroxy-ellipticine (NSC 264-137) in the treatment of malignant metastases. Preliminary results (author's transl)].
Topics: Alkaloids; Antineoplastic Agents; Breast Neoplasms; Ellipticines; Hemolysis; Humans; Kidney Neoplasms; Neoplasm Metastasis; Sarcoma; Soft Tissue Neoplasms | 1981 |
In vivo antitumor activity of S 16020-2, a new olivacine derivative.
Topics: Adenocarcinoma; Administration, Oral; Animals; Antineoplastic Agents; Blood Cell Count; Bone Marrow; Breast Neoplasms; Carcinoma, Lewis Lung; Carcinoma, Non-Small-Cell Lung; Doxorubicin; Drug Administration Schedule; Drug Resistance, Neoplasm; Ellipticines; Female; Humans; Injections, Intraperitoneal; Injections, Intravenous; Leukemia P388; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Tumor Cells, Cultured | 1996 |
Elliptinium acetate in metastatic breast cancer--a phase II study.
Topics: Adult; Aged; Alkaloids; Antineoplastic Agents; Breast Neoplasms; Drug Evaluation; Ellipticines; Female; Humans; Middle Aged; Neoplasm Metastasis | 1990 |
Elliptinium: phase II study in advanced measurable breast cancer.
Topics: Adenocarcinoma; Adult; Aged; Alkaloids; Antineoplastic Agents; Breast Neoplasms; Drug Evaluation; Ellipticines; Female; Humans; Middle Aged; Neoplasm Metastasis | 1989 |
Pharmacokinetic study of 14C-radiolabelled elliptinium acetate in patients with metastatic breast cancer.
Topics: Alkaloids; Antineoplastic Agents; Breast Neoplasms; Chemical Phenomena; Chemistry; Ellipticines; Female; Humans; Middle Aged; Neoplasm Metastasis | 1988 |
Drug-induced antibodies during 2-N-methyl-9-hydroxyellipticinium acetate (NSC-264137) treatment: schedule dependency and relationship to hemolysis.
Topics: Alkaloids; Anemia, Hemolytic; Antibodies; Breast Neoplasms; Ellipticines; Female; Humans; Prospective Studies; Retrospective Studies; Risk | 1985 |
Phase II study of elliptinium in advanced breast cancer.
Topics: Acute Kidney Injury; Adult; Aged; Alkaloids; Antineoplastic Agents; Breast Neoplasms; Drug Evaluation; Ellipticines; Female; Hemolysis; Humans; Immunoglobulin M; Middle Aged; Soft Tissue Neoplasms | 1985 |